Rho

Rho, established in 1984, is a privately-held contract research organization (CRO) headquartered in Chapel Hill, North Carolina. The firm specializes in providing comprehensive clinical research services throughout the entire drug development lifecycle. By leveraging deep expertise in biotechnology, pharmaceuticals, and medical device development, Rho supports clients with regulatory consulting, clinical data management, and trial implementation. The organization maintains a robust operational footprint across two locations, ensuring high-quality compliance and research support for complex clinical trials.

With a workforce of 500-1,000 employees, Rho delivers specialized technical services including clinical trial design, data analysis, and regulatory submission support. The company’s operational model emphasizes scientific rigor and functional capacity to meet the evolving needs of the global healthcare sector. Meet Rho's team to learn about their leadership and the technical expertise driving their clinical research initiatives. Their commitment to operational excellence is reflected in their long-standing history of supporting federal and commercial research projects, positioning them as a reliable partner for organizations navigating the intricacies of modern drug development and clinical compliance.

Rho demonstrates significant market presence within the competitive CRO landscape, reporting annual revenue of $105.7M. The company maintains a strategic focus on high-value clinical services, competing with firms such as Advanced Clinical and Bioagilytix. Explore financial highlights for detailed metrics regarding their fiscal performance and funding history, including recent debt financing. By integrating advanced data management systems and maintaining a strong regulatory consulting practice, Rho continues to scale its operations to address the demands of the pharmaceutical and biotechnology industries.